Who cytology screening

How often should you get a cytology screening?
People aged 25 to 49 receive invitations every 3 years.
People aged 50 to 64 receive invitations every 5 years.
Cervical screening is not recommended for anyone under 25 years old who has not been invited..
What is screening in cytology?
Cervical screening looks for the human papillomavirus ( HPV ) which can cause abnormal cells on the cervix.
If HPV is found a cytology test is used as a triage, to check for any abnormal cells.
If no abnormal cells are found, a follow up screen is arranged for 12 months' time..
Who criteria for an effective cancer screening programme?
the condition should be an important health problem. there should be a recognisable latent or early symptomatic stage. the natural history of the condition, including development from latent to declared disease, should be adequately understood. there should be an accepted treatment for patients with recognised disease..
WHO guidelines for cervical screening?
Screening should start from 30 years of age in the general population of women, with regular screening with a validated HPV test every 5 to 10 years, and from 25 years of age for women living with HIV.
Women living with HIV also need to be screened more frequently, every 3 to 5 years..
The HPV test involves inserting a speculum (small instrument) into the vagina so your doctor can see the cervix and then obtain a cell sample with a small brush, spatula, or scraper.
It takes a few seconds and should be painless.
If you're getting a Pap smear at the same time, the sample will be used for both tests.

New programmes should start by screening women aged 30 years or more, and include younger women only when the higher-risk group has been covered. If a woman can be screened only once in her lifetime, WHO recommends the best age is between 35 and 45 years.

Cervical cancer screening aims to detect precancerous changes, which, if not treated, may lead to cancer. In resource-poor settings, 30 to 49 year old women

How effective is cytology-based cervical cancer screening?

In countries with efective cytology-based cervical cancer screening and treatment programmes, the mortality from cervical cancer has been reduced fivefold over the past 50 years (6).
This screening approach has not been as successful in low- and middle-income countries (7).

Is cytology screening effective?

Even though the efficacy of cytology screening has never been proven through randomized trials, it is generally agreed that it has been effective in reducing the incidence of and mortality from the disease in developed countries (20-24).

When did cytology smears become a standard for cervical screening?

After the 1950s, when cytology smears became the standard for cervical screening, the colposcope (initially devel- oped in the 1930s) began to be used increasingly to further investigate screen-positive women and to direct biopsies in order to confirm screening findings.

Who should be referred to a cytology laboratory?

Institution(s) and individuals to whom women with abnormal cytology test results will be referred.
Institution(s) and individuals who will be in charge of the centralized pathology laboratory to evaluate biopsy specimens (should be the same laboratory to which smears are sent for examination).

Who cytology screening

How often should you get a cytology screening?

What is screening in cytology?

Who criteria for an effective cancer screening programme?

WHO guidelines for cervical screening?

How effective is cytology-based cervical cancer screening?

Is cytology screening effective?

When did cytology smears become a standard for cervical screening?

Who should be referred to a cytology laboratory?